Imunon IMNN
NASDAQ IMNN
$1.62 +0.04 (+2.53%)
As of: Aug 21, 2026 · 3:56 PM EDT

Imunon (IMNN) EPS (Basic) (2010 - 2026)

Imunon's (IMNN) quarterly EPS (Basic) came in at -$0.87 in Q1 2026, up 80.23% YoY from -$0.48 in Q1 2025, and up 57.49% on a QoQ basis from -$2.04 in Q4 2025.

Imunon (IMNN) EPS (Basic) (2010 - 2026) Analysis & Trends

Imunon (IMNN) has 17 years of EPS (Basic) data on file, last reported at -$0.87 in Q1 2026.

  • Quarterly EPS (Basic) rose 80.23% year-over-year to -$0.87 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.26 (up 83.18% YoY) and the FY2025 annual result came in at -$42.99, down 77.12% from the prior year.
  • EPS (Basic) advanced to -$0.87 in Q1 2026, from -$2.04 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.87 in Q1 2026 to a low of -$23.26 in Q4 2022.
  • A 5-year average of -$8.16 and a median of -$8.13 in 2024 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2022 — EPS (Basic) plunged 153.69% — and 2026, when it surged 80.23%.
  • Tracing IMNN's EPS (Basic) over 5 years: stood at -$23.26 in 2022, then soared by 56.87% to -$10.03 in 2023, then jumped by 45.49% to -$5.47 in 2024, then jumped by 62.61% to -$2.04 in 2025, then surged by 57.49% to -$0.87 in 2026.
  • The last three EPS (Basic) figures came in at -$0.87 (Q1 2026), -$2.04 (Q4 2025), and -$1.22 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 Imunon 8.42 Mn 8.42 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.87
Dec 31, 2025 -2.04
Sep 30, 2025 -1.22
Jun 30, 2025 -3.22
Mar 31, 2025 -4.40
Dec 31, 2024 -5.47
Sep 30, 2024 -5.42
Jun 30, 2024 -8.23
Mar 31, 2024 -8.13
Dec 31, 2023 -10.03
Sep 30, 2023 -5.88
Jun 30, 2023 -8.76
Mar 31, 2023 -10.16
Dec 31, 2022 -23.26
Sep 30, 2022 -13.04
Jun 30, 2022 -13.08
Mar 31, 2022 -15.54
Dec 31, 2021 43.32
Sep 30, 2021 -13.53
Jun 30, 2021 -13.86